Transplantation of Cord-Blood Stem Cells into a Patient with Severe Thalassemia

  • Issaragrisil S
  • Visuthisakchai S
  • Suvatte V
  • et al.
90Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Several different kinds of thalassemia and hemoglobinopathy are prevalent in Southeast Asia.1,2 The frequency of the α-thalassemias reaches 30 to 40 percent in northern Thailand, whereas the β-thalassemias occur at a frequency of 3 to 9 percent. Hemoglobin E, the hallmark hemoglobinopathy of Southeast Asia, occurs at a frequency of 50 to 60 percent at the junction of Thailand, Laos, and Cambodia. Mutation and gene interaction account for more than 60 different clinical syndromes. Of these, homozygous β-thalassemia and hemoglobin E –β-thalassemia disease are the most common and the most severe clinical syndromes compatible with live birth. Hemoglobin E–β-thalassemia.  . . © 1995, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Issaragrisil, S., Visuthisakchai, S., Suvatte, V., Tanphaichitr, V. S., Chandanayingyong, D., Schreiner, T., … Piankijagum, A. (1995). Transplantation of Cord-Blood Stem Cells into a Patient with Severe Thalassemia. New England Journal of Medicine, 332(6), 367–369. https://doi.org/10.1056/nejm199502093320605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free